Nantahala Capital Management, LLC 13D and 13G filings for Aeglea BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:55 pm Purchase |
2022-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Nantahala Capital Management, LLC | 184,452 7.500% |
71,910 (+63.90%) |
Filing |
| 2022-02-14 08:01 am Purchase |
2021-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Nantahala Capital Management, LLC | 112,542 5.700% |
15,982 (+16.55%) |
Filing |
| 2021-02-16 10:21 am Sale |
2020-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE |
Nantahala Capital Management, LLC | 96,560 4.900% |
-17,530 (-15.37%) |
Filing |